Expoint - all jobs in one place

Finding the best job has never been easier

Limitless High-tech career opportunities - Expoint

Boston Scientific Senior Clinical Research Scientist 
United States, Massachusetts, Marlborough 
578132311

28.06.2024

Required qualifications:

  • Bachelor's degree in sciences or healthcare related field, Masters/ PhD is preferred.
  • Minimum 2 years of clinically applied science, or clinical/medical research experience
  • Demonstrate understanding of medical science and clinical therapies.
  • Ability to travel approximately 20% as needed.

Preferred qualifications:

  • Strong scientific writing and communication skills
  • Analytical skills, including ability to review and synthesize medical literature efficiently and effectively.
  • Prior experience with clinical trials, including IDE, or feasibility studies strongly desired (Sponsor/ CRO (Contract Research Organizations) or other industry experience)

Among other requirements, Boston Scientific maintains specific prohibited substance testing requirements for safety-sensitive positions. This role is deemed safety-sensitive and, as such, candidates will be subject to a drug test as a pre-employment requirement. The goal of the drug testing is to increase workplace safety in compliance with the applicable law.

Please be advised that certain US based positions, including without limitation field sales and service positions that call on hospitals and/or health care centers, require acceptable proof of COVID-19 vaccination status. Candidates will be notified during the interview and selection process if the role(s) for which they have applied require proof of vaccination as a condition of employment. Boston Scientific continues to evaluate its policies and protocols regarding the COVID-19 vaccine and will comply with all applicable state and federal law and healthcare credentialing requirements. As employees of the Company, you will be expected to meet the ongoing requirements for your roles, including any new requirements, should the Company’s policies or protocols change with regard to COVID-19 vaccination.